PNC Financial Services Group Inc. Sells 793 Shares of Maximus, Inc. $MMS

PNC Financial Services Group Inc. lowered its position in Maximus, Inc. (NYSE:MMS) by 32.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,682 shares of the health services provider’s stock after selling 793 shares during the period. PNC Financial Services Group Inc.’s holdings in Maximus were worth $115,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the company. LRI Investments LLC grew its holdings in shares of Maximus by 11.9% in the first quarter. LRI Investments LLC now owns 1,833 shares of the health services provider’s stock worth $125,000 after acquiring an additional 195 shares during the period. Vestcor Inc grew its holdings in shares of Maximus by 2.3% in the first quarter. Vestcor Inc now owns 9,877 shares of the health services provider’s stock worth $674,000 after acquiring an additional 223 shares during the period. Cetera Investment Advisers grew its holdings in shares of Maximus by 5.8% in the first quarter. Cetera Investment Advisers now owns 4,519 shares of the health services provider’s stock worth $308,000 after acquiring an additional 247 shares during the period. UMB Bank n.a. grew its holdings in shares of Maximus by 70.2% in the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider’s stock worth $41,000 after acquiring an additional 250 shares during the period. Finally, Nisa Investment Advisors LLC lifted its position in Maximus by 0.7% during the first quarter. Nisa Investment Advisors LLC now owns 39,936 shares of the health services provider’s stock valued at $2,723,000 after purchasing an additional 290 shares in the last quarter. Institutional investors own 97.21% of the company’s stock.

Insider Activity

In other news, Director Gayathri Rajan sold 7,913 shares of Maximus stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $72.38, for a total value of $572,742.94. Following the sale, the director directly owned 14,205 shares of the company’s stock, valued at approximately $1,028,157.90. The trade was a 35.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.60% of the company’s stock.

Maximus Price Performance

NYSE:MMS opened at $84.9250 on Wednesday. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91. The business’s 50-day simple moving average is $73.58 and its two-hundred day simple moving average is $70.83. The stock has a market cap of $4.79 billion, a PE ratio of 15.64 and a beta of 0.60. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.94.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.77. The business had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.29 billion. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The business’s quarterly revenue was up 2.5% on a year-over-year basis. During the same period last year, the firm earned $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, August 15th. Maximus’s payout ratio is 22.10%.

Analysts Set New Price Targets

Separately, Wall Street Zen downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Thursday, May 15th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $90.00.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.